LONDON (Alliance News) - <strong>Marks and Spencer</strong> Group PLC is planning to open 250 new stores outside the UK over the next three years, as part of its global expansion plans.<br /><br />M&S currently operates a total of 455 stores in 53 territories outside the UK, as well as nin Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said a group of non-executives was awarded shares and American Depositary Shares at GBP16.08 per share and USD53.75 each respectively Monday.<br /><br />Details are as follows.<br /><br /> <table class="ae" style="width: 400px; height: Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.<br /><br />-------<br /><br />FTSE 100 - WINNERS<br /><br /><strong>Marks and Spencer</strong> Group, up 2.4%. The retailer has announced that it is planning to ope Read More
LONDON (Alliance News) - The following is a summary of top news stories Wednesday.<br />----------<br /><strong>COMPANIES</strong><br />---------- <strong>BP</strong> PLC announced it intends to halt refinery operations at its major Bulwer Island refinery in Brisbane, Australia by mid-20 Read More
LONDON (Alliance News) - Shares have opened flat to slightly down Wednesday, despite a record close in the US and strong UK house price data.<br /><br />Goldman Sachs has added <strong>Go-Ahead</strong> Group to its Conviction Buy List with a price target of 2,310 pence. The bus and train comp Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Wednesday said it had chosen to stop the Phase III trial of its MAGE-A3 cancer immunotherapeutic in non-small cell lung cancer patients, as it said it would not be possible to identify a sub-population of MAGE-A3 positive patients with a specific gene Read More
LONDON (Alliance News) - <strong>Weir Group</strong>'s takeover approach to Finnish rival Metso is the biggest of a flurry of deals and potential deals announced Tuesday, with <strong>GKN</strong> acquiring the William's Formula 1 team parent's hybrid engine unit and <strong>Capita</strong> bo Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday a Phase III study of patients with advanced renal cell carcinoma showed that 70% of patients preferred Glaxo's Votrient treatment to Sutent, which is owned by CP Pharmaceuticals International C.V. CP Pharmaceuticals is comprised of Read More
LONDON (Alliance News) - <strong>Babcock International Group</strong> is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.<br /><br />The joint venture with Fluo Read More
LONDON (Alliance News) - <strong>Babcock International Group</strong> is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.<br /><br />The joint venture with Flou Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that it has withdrawn its marketing authorisation application for its advanced ovarian cancer maintenance therapy Votrient in the EU. The application was in relation to an additional indication of the treatment of women with FIGO stag Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.<br /><br />-------<br /><br />FTSE 100 - WINNERS<br /><br /><strong>Babcock</strong> International Group, up 3.5%. The company said its Cavendish Fluor Partnership has Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Babcock</strong> International Group PLC said its Cavendish Fluor Partnership has been selected as the preferred bidder in the competitio Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Monday announced a series of new investments in sub-Saharan Africa of up to GBP130 million over the next five years to increase access to medicines, build its capacity and contribute to its long-term business growth. Glaxo said it plans to build Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that its Phase III STABILITY study for darapladib in the treatment of patients with chronic coronary heart disease failed to meet its primary endpoint, although it said that the effects of the drug on the reduction of coronary events was of Read More
LONDON (Alliance News) - Shares have opened higher Monday ahead of a week with a full calendar of economic data reports scheduled.<br /><br /><strong>Rolls-Royce</strong> Holdings PLC said it has won a deal worth more than USD50 million to support the US Marines Corps' fleet of KC-130J air-to- Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Friday that it had acquired full ownership of its Indonesian Consumer Healthcare business for IDR465 billion, equivalent to GBP24.6 million, and sold its non-core brand and manufacturing facility in the country. The company bought the remain Read More
LONDON (Alliance News) - NASDAQ-listed Myland Inc said Thursday that it has won its breach of contract case against UK pharmaceutical giant GlaxoSmithKline PLC. The jury of the United States District Court for New Jersey decided that Glaxo owes Mylan USD106.7 million in damages, over charge Read More
CANONSBURG (Alliance News) - Mylan Inc. said Thursday that, after a trial in the US District Court for the District of New Jersey, a jury returned a verdict in favour of Mylan in its breach of contract lawsuit against GlaxoSmithKline relating to Paroxetine Hydrochloride Extended-release or ER Tab Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday announced a new research collaboration with the European Bioinformatics Institute and the Wellcome Trust Sanger Institute, to harness 'big data' and genome sequencing to improve the success rate for discovering new medicines. The three w Read More